Clinical Pharmacist and Master’s student in Clinical Pharmacy with research interests in pharmacovigilance, behavioral interventions in mental health, and AI applications in clinical decision support. Experience includes digital health research with Bloomsbury Health (London) and pharmacovigilance practice in patient support programs. Published work covers drug awareness among healthcare providers, postpartum depression management, and patient safety reporting.
2025-10-03 07:15:42
Metal-Microbiota Interactions: Omic Tools for CertificationThis review explores how metals interact with the gut microbiota, impacting host health via the gut-brain axis. It evaluates advanced omic tools for assessment, providing critical insights for refining heavy metal safety evaluations and certification standards.
2025-10-02 23:22:35
Biosorption of Heavy Metals for Eco-Friendly Wastewater TreatmentThis review highlights biosorption as an economical, eco-friendly alternative for heavy metal removal, summarizing microbial, algal, fungal, and waste-based biosorbents, their mechanisms, and industrial applications relevant to certification programs.
2025-10-02 23:02:58
Fungal Community Diversity in Heavy Metal Contaminated Soils: Insights for Certification and BioremediationThis study used metagenomics to reveal fungal community diversity in heavy metal contaminated soils, showing lead’s severe impact and identifying tolerant genera and functional genes relevant for bioremediation and certification.
2025-10-02 22:48:43
Heavy Metal Exposure Gut Microbiome: Impacts on Metabolic Health and Certification StandardsThis study demonstrates that chronic exposure to arsenic and cadmium disrupts the gut microbiome and metabolome in mice, notably reducing butyrate producers and altering metabolites linked to metabolic health, providing critical evidence for the importance of rigorous heavy metal certification in consumer safety.
2025-10-02 08:23:15
Nickel Compound Carcinogenicity Assessment — Risks, Thresholds, and Certification ImplicationsThis review integrates epidemiological, animal, and mechanistic data to clarify the carcinogenic risks of nickel subsulfide, nickel oxide, and nickel sulfate, underscoring the critical role of chemical speciation for regulatory and certification standards.
2025-10-02 08:08:20
Nickel Arsenic Chromium Carcinogenesis — Epigenetic Risks and HMTC Regulatory InsightsThis review outlines how nickel, arsenic, and chromium drive cancer mainly through epigenetic mechanisms, DNA repair inhibition, and cocarcinogenicity, offering key insights for HTMC regulation.
2025-10-01 11:31:53
Nickel Human Health Toxicity — Evidence-based Implications for HMTC Certification and Regulatory TestingA targeted synthesis of nickel’s environmental sources, toxic mechanisms (oxidative stress, mitochondrial damage, epigenetic effects), clinical outcomes, and remediation options—framed for regulatory testing and certification.
2025-10-01 09:57:54
Nickel Exposure in Pregnancy Complications: Placental Barrier and Fetal Risk InsightsPregnancy complications weaken the placental barrier to nickel, increasing fetal exposure and potential health risks. Even low-level environmental nickel can affect fetal development, emphasizing the need for stricter exposure controls in pregnant women, especially those with gestational diseases.
2025-10-01 09:52:07
Role of Nickel in Microbial Pathogenesis: Urease, Hydrogenase, and HMTCThe review “Role of Nickel in Microbial Pathogenesis” surveys how Ni-dependent enzymes, transporters, and host sequestration shape microbial virulence and identifies Ni acquisition and urease/hydrogenase systems as actionable points for HTMC-style regulation.
2025-10-01 09:50:18
Nickel Exposure and Cardio-Metabolic Health: Implications for Heavy Metal CertificationWhat was reviewedThis narrative review examined clinical, epidemiological, and experimental research on nickel’s
